.Attributes Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective calls for addition of clients along with MASLD and size of liver end results in cardio-- renal-- metabolic trials, when information recommend mechanistically conceivable advantages and also medical security-- and also summarizes factors to consider for trial style and also regulative approval.